Session date:
01/19/2017 - 12:30pm to 1:30pm
During this session the learning objectives are:
To describe the pharmacology and neuropharmacology of dexmedetomidine.
To summarize the indications and available evidence for ketamine administration in the critical care setting.
To examine a variety of emerging concepts regarding ketamine administration in combination with propofol for induction and maintenance of procedural sedation.
To recognize the unique pharmacokinetic properties of remifentanil.
To provide succinct, evidence-based, practical considerations for the administration of remifentanil.
Presenter:
Troy G. Seelhammer, MD
Where did the idea for the course originate?:
Minnesota
Where did the idea for the course originate?:
Minnesota

Facebook
X
LinkedIn
Forward